memorial sloan kettering cancer center

Pancreatic cancer vaccine shows promise

Experimental vaccine for common cancer shows potential in clinical trial

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.

CBS News on MSN · 4d

Vaccine targeting pancreatic cancer shows promise in new study of clinical trial

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage pancreatic cancer patients.

Medical Xpress · 1d

Vaccine shows promise for pancreatic cancer, study finds

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet promising study from Memorial Sloan Kettering Cancer Center.

Science Friday · 2d

A Vaccine For Pancreatic Cancer Continues To Show Promise

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.

Interesting Engineering on MSN · 3d

New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years

Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

STAT2d

The ironic origin story behind Sloan Kettering

Sloan Kettering is one of the world’s leading cancer centers. It was founded by two men who created and sold leaded gasoline ...

It's a Miracle! Cancer center event gets cynical New Yorkers to agree on something

Proceeds from sales at participating 'Miracle in Palm Beach' stores benefit MSK Kids, the pediatric program at Memorial Sloan ...

Becker's Hospital Review4d

Memorial Sloan Kettering, Amazon partner on cancer innovation

New York City-based Memorial Sloan Kettering Cancer Center has partnered with Amazon Web Services to accelerate cancer innovation and research through AI, high-performance computing and cloud ...

aha.org10d

Rectal cancer disappears after experimental use of immunotherapy

A clinical trial at Memorial Sloan Kettering Cancer Center has achieved groundbreaking results in treating rectal cancer using Jemperli.

MedCity News6d

Memorial Sloan Kettering Teams Up with AWS to Speed Up Drug Discovery

For instance, AI can examine patient data to predict the likelihood of developing certain diseases and the associated trajectory of disease burden, which allows for early interventions and ...

AWS expands AI in healthcare through a Memorial Sloan Kettering partnership

Amazon Web Services ( AMZN) has been increasing its partnerships with health companies to advance AI capabilities in ...

2don MSN

Experimental vaccine for common cancer shows potential in clinical trial; here’s what we know

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results